期刊文献+

免疫抑制剂治疗激素耐药性肾病综合征临床观察 被引量:7

暂未订购
导出
摘要 肾病综合征是泌尿内科常见疾病,绝大多数患者通过激素治疗后均能得到满意的治疗效果。但是有的患者对激素产生耐受,出现激素耐药性肾病综合征,其主要是指患者在接受常规激素(1.5~2.0mg·kg-1·d-1)治疗,4~8周后尿蛋白仍然出现++以上。目前激素耐药性肾病综合征已经成为临床医生的所面临的较为严峻问题,治疗过程中往往需要激素联合免疫抑制剂才能得到满意的治疗效果0。
作者 王港
出处 《河北医药》 CAS 2012年第5期728-729,共2页 Hebei Medical Journal
  • 相关文献

参考文献6

  • 1钮小玲,黄文彦.PLCE1基因突变与激素耐药性肾病综合征的关系[J].国际病理科学与临床杂志,2009,29(4):337-341. 被引量:6
  • 2SkálováS,Podhola M,Vondrák K,et al.Plasmapheresis-induced clinical improvement in a patient with steroid-resistant nephrotic syndrome due to podocin(NPHS2)gene mutation.Acta Medica,2010,53:157-159.
  • 3Traum AZ.Urine proteomic profiling to identify biomarkers of steroid re-sistance in pediatric nephrotic syndrome.Expert Rev Proteomics,2008,5:715-719.
  • 4Chen P,Jiang T,Ouyang J,et al.Glucocorticoid receptor auto-upregula-tion and its relation with glucocorticoid sensitivity in idiopathic nephrotic syndrome.Int Urol Nephrol,2011,43:167-174.
  • 5Ma Z,Gao X,Zhao W,et al.Relationship between expression of Pad1homologue and multidrug resistance of idiopathic nephrotic syndrome.Pe-diatr Int,2009,51:732-735.
  • 6Jang HR,Jung HW,Lee YJ,et al.Combination treatment with corticoste-roid,cyclosporine A,and mycophenolate in refractory nephrotic syn-drome.Clin Nephrol,2011,75:511-517.

二级参考文献25

  • 1Wing MR, Bourdon DM, Harden TK. PLC-epsilon:a shared effector protein in Ras-, Rho-, and Gαβγ-mediated signaling [ J]. Mol Interv, 2003, 3 (5):273-280.
  • 2Kelley GG, Reks SE, Ondrako JM, et al. Phospholipase C (epsilon) :a novel Ras effector [J]. EMBO J, 2001, 20 (4):743- 754.
  • 3Hinkes B, Wiggins RC, Gbadegesin R, et al. Positional cloning uncovers mutations in PLCE1 responsible for a nephritic syndrome variant that may be reversible [J]. Nat Genet, 2006,38 (12) : 1397-1405.
  • 4Cockcroft S. The latest phospholipase C, PLCeta, is implicated in neuronal function [ J ] . Trends Biochem Sci, 2006, 31 ( 1 ) :4-7.
  • 5Song C, Satoh T, Edamatsu H, et al. Differential roles of Ras and Rap 1 in growth factor dependent activation of phospholipase C epsilon [J]. Oncogene, 2002, 21 (53) :8105-8113.
  • 6Kelley GG, Kaproth-Josln KA, Reks SE, et al. G protein.coupled receptor agenists activate endogenous phospholipase C epsilon and phospholipase C beta 3 in a temporally distinct manner [J]. J Biol Chem, 2006, 281 (5) :2639-2648.
  • 7Evellin S, Nolte J, Tysack K, et al. Stimulation of phospholipase C-epsilon by the M (3) muscarinic acetylcholine receptor mediated by cyclic AMP and the GTPase Rap2B [J]. J Biol Chem, 2002, 277 (19) :16805-16813.
  • 8Ada-Nguema AS, Xentas H, Hofman JM, et al. The small GTPase R-Ras regulates organization of actin and drives membrane protrusions through the activity of PLC epsilon [ J ] . J Cell Sci, 2006, 119 (Pt7) :1307-1319.
  • 9Wang H, Oestreich EA, Maekawa N, et al. Phospholipase C epsilon modulates beta-adrenergic receptor-dependent cardiac contraction and inhibits cardiac hypertrophy [ J ]. Cite Res, 2005, 97 (12) :1305-1313.
  • 10Quaggin SE, Kreidberg JA. Development of the renal glomerulus: good neighbors and good fences [ J ]. Development, 2008, 135 (4) :609-620.

共引文献5

同被引文献55

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部